1g IV q24h
Targeted therapy of ESBL infections and other resistant gram negative infections.
Empiric therapy when broad spectrum of carbapenems is desired without the need for anti-pseudomonal activity.
Immediate and delayed-type allergy
Cytopenias, eosinophilia, positive Coombs
Liver enzyme abnormalities
Seizure risk lower than other carbapenems
Antimicrobial class: Carbapenem
Pregnancy category: B
Average serum half life: 4.0
Urine penetration: Therapeutic
Lung penetration: Therapeutic
Biliary penetration: Moderate